Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Feb 2024 for Cyteir Therapeutics, Inc., €22k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jean George: trading record in brief
Jean George is a declared insider of Cyteir Therapeutics, Inc. (board member), with filings sourced from SEC (Form 4). Over a trading history stretching from 22 June 2021 to 14 February 2024, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 16 February 2024 came the latest disclosure, an option exercise for €22k in Cyteir Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jean George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
14,150 shares@ US$1.69100.0% of flowCommon StockSEC:0001209191-24-003437:0
2,444,268 sharesCommon StockSEC:0000899243-21-025821:0
2 of 2 declarations
